Associated Papers
Mutated G proteins as drug targets.
Noorman van der Dussen K et al.
Trends in Pharmacological Sciences, 2025
A Novel Maternally Inherited GNAS Variant in a Family With Hyperphagia and Obesity: 3 Cases.
Ramakrishnan A et al.
Jcem Case Reports, 2024
Z-flipon variants reveal the many roles of Z-DNA and Z-RNA in health and disease.
Umerenkov D et al.
Life Science Alliance, 2023
37164635 (PubMed )
Supplement: LSA-2023-01962_TableS6.xlsx › Predicted_OMIM
Obesity-Associated GNAS Mutations and the Melanocortin Pathway.
Mendes de Oliveira E et al.
The New England Journal of Medicine, 2021
Identification of MicroRNA-Related Tumorigenesis Variants and Genes in the Cancer Genome Atlas (TCGA) Data.
Li C et al.
Genes, 2020
32824926 (PubMed )
Supplement: genes-11-00953-s001.zip › Table_S1.xlsx › Sheet1
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network.
Thiele S et al.
European Journal of Endocrinology, 2016
GNAS mutations in Pseudohypoparathyroidism type 1a and related disorders.
Lemos MC et al.
Human Mutation, 2015
25219572 (PubMed )
Supplement: humu0036-0011-sd1.pdf
Mutations in pseudohypoparathyroidism 1a and pseudopseudohypoparathyroidism in ethnic Chinese.
Wu YL et al.
Plos One, 2014
GNAS -Related Loss-of-Function Disorders and the Role of Imprinting.
Linglart A et al.
Hormone Research in Paediatrics, 2013
Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsα-receptor interaction.
Thiele S et al.
Human Mutation, 2011
Select a paper to view details